Skip to main content

FDA recall, , Moderate risk

Spacelabs Healthcare Multi-Parameter Command Module

The Multi-parameter Command Module has a circuit board issue that may cause inaccurate readings and delayed care.

What happened

Spacelabs Healthcare, Inc., of Snoqualmie, Washington, began a recall on February 27, 2026, of its Multi-parameter Command Module, Model 91496, optioned with Masimo or Nellcor, due to a circuit board issue.

In Auto mode, Cardiac Output measurement may activate early, causing Bad Curve error with no CO measurement or Irregular Curve error with CO measurement not automatically excluded, which may result in inaccurate readings or the need for additional readings, potentially leading to delayed care and/or fluid overload.

The FDA added the recall to its Enforcement Report on April 7, 2026, with nationwide distribution including states such as New York, New Jersey, and Texas, and international distribution to countries including Canada, France, and Mexico.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Multi-parameter Command Module

    Model number
    • 91496
    • optioned with Masimo or Nellcor
    UDI-DI
    • 10841522106415
    • 10841522106422

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution including in the states of New York, New Jersey, Alabama, Oklahoma, Iowa, Montana, Wyoming, Minnesota, Texas, Wisconsin, Pennsylvania, Washington, Oregon, Michigan, California, South Carolina, Idaho, Florida, Mississippi, Kansas, South Dakota, Louisiana, Ohio, Missouri, New Hampshire, Georgia, Maryland, Tennessee, Arizona, PR and the countries of TAIWAN, CANADA, KUWAIT, FRANCE, SAUDI ARABIA, POLAND, PAKISTAN, MEXICO, ARGENTINA, PANAMA.

Company
Spacelabs Healthcare, Inc.Snoqualmie, Washington
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98374
Recall number
Z-1793-2026

All recalls from Spacelabs Healthcare, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)